|
HY-P73903-100ug
|
MedChemexpress LLC
|
IgG1, Human (CHO)
|
|
|
|
|
HY-P70771-10ug
|
MedChemexpress LLC
|
IgG4 Fc, Human (HEK293)
|
|
|
|
|
HY-P70771-50ug
|
MedChemexpress LLC
|
IgG4 Fc, Human (HEK293)
|
|
|
|
|
HY-P5271-1mg
|
MedChemexpress LLC
|
Influenza hemagglutinin (HA) epitope [CAS 92000-72-1]
|
|
|
|
|
HY-P5271-10mg
|
MedChemexpress LLC
|
Influenza hemagglutinin (HA) epitope [CAS 92000-72-1]
|
|
|
|
|
HY-P5271-5mg
|
MedChemexpress LLC
|
Influenza hemagglutinin (HA) epitope [CAS 92000-72-1]
|
|
|
|
|
HY-122907-10mg
|
MedChemexpress LLC
|
JNJ4796 [CAS 2241664-16-2]
|
|
COVID-19-anti-virus
|
|
|
HY-122907-25mg
|
MedChemexpress LLC
|
JNJ4796 [CAS 2241664-16-2]
|
|
COVID-19-anti-virus
|
|
|
HY-122907-5mg
|
MedChemexpress LLC
|
JNJ4796 [CAS 2241664-16-2]
|
|
COVID-19-anti-virus
|
|
|
HY-P99175-1mg
|
MedChemexpress LLC
|
KWAR 23 [CAS 2243227-60-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P99175-10mg
|
MedChemexpress LLC
|
KWAR 23 [CAS 2243227-60-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P99175-5mg
|
MedChemexpress LLC
|
KWAR 23 [CAS 2243227-60-1]
|
|
Cancer-programmed cell death
|
|
|
HY-W087027-100mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W087027-25mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W087027-50mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-10mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-100mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-25mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-5mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-50mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
